Novo Nordisk falls after Reuters report of Hims launching Wegovy pill copy
Shares of Danish drugmaker Novo Nordisk NOVOb.CO fall as Reuters reports that Hims and Hers Health HIMS.N is launching copies of Novo's Wegovy pill at an introductory price of $49 per month
Novo Nordisk's Denmark-listed shares down 7% at 283 Danish crowns; U.S. shares NVO.N fall 3.9%
Hims says its compounded pill uses semaglutide, the same active ingredient as Wegovy, and will cost $99 a month after an initial payment, compared with Novo's $199
Hims and Hers shares jump 10%
*Novo's obesity rival Eli Lilly LLY.N down 5%
Novo last year ended a partnership with Hims and has raised safety and marketing concerns about compounded Wegovy copies
Earlier this week, Novo forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market
Novo shares down ~42% in 2025
Related Articles
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).
Why Sanae Takaichi Winning Japan’s Diet Election Led to a Surge in Japanese Stock Indices？
TradingKey - Reports indicate that the ruling coalition led by Japanese Prime Minister Sanae Takaichi has secured a single-party majority in the parliamentary elections held on Sunday (February 8). Following the news, the yen weakened slightly, while the Nikkei Index surpassed 57,000 for the first t
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
Is Bitcoin’s Four-Year Cycle Dead in 2026?
Is the Bitcoin 4-year cycle dead? After 2025 broke historical records with a red post-halving year, institutional analysts explore if the Bitcoin price has decoupled from the halving countdown. Analyze the impact of spot ETFs, global liquidity, and the roadmap to the 2028 halving in this 2026 market
